Abiopharma

News list

📋 Robert J. Alpern (Retired Director) plans to sell 29K shares of ABBOTT LABORATORIES (at $92.55 each, total $2.7M) Filed: Apr 27, 2026 | ID: 000010

Full text

News bot April 27, 2026, 10:34 p.m.
📋 Form 144 Filing: Robert J. Alpern

Company: ABBOTT LABORATORIES

Filing Date: 2026-04-27

Relationship: Retired Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 29,211
- Price per Share: $92.55
- Total Value: $2,703,457.00
- Planned Sale Date: 2026-04-27
- Broker: UBS Financial Services, Inc.
- Exchange: NYSE
Additional Information:
- SEC File Number: 001-02189
- Issuer Contact Phone: 224-667-6100
- Issuer Address: 100 ABBOTT PARK ROAD, ABBOTT PARK, IL, 60064
- Broker Address: 1000 Harbor Blvd. 3rd Floor, Weehawken, NJ, 07086
- Shares Outstanding: 1737682887.0
- Number of Securities to be Sold: 14
- Signature: /s/ Robert J. Alpern by Aaron N. Rice , Attorney-in-Fact